The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ruxolitinib in polycythemia vera: Follow-up from the RESPONSE trial.
 
Srdan Verstovsek
Research Funding - Incyte (Inst)
 
Alessandro M. Vannucchi
Consulting or Advisory Role - Novartis
Speakers' Bureau - Novartis; Shire
Research Funding - Novartis (Inst)
 
Martin Griesshammer
Travel, Accommodations, Expenses - Amgen; Novartis; Roche Pharma AG; Shire
 
Tamás Masszi
Consulting or Advisory Role - Janssen-Cilag; Novartis
 
Simon Durrant
No Relationships to Disclose
 
Francesco Passamonti
No Relationships to Disclose
 
Claire N. Harrison
Honoraria - Baxter; CTI; Novartis; Sanofi
Speakers' Bureau - Baxter; CTI; Novartis; Sanofi; Shire
Research Funding - Celgene (Inst); CTI (Inst); Gilead Sciences (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Novartis
 
Fabrizio Pane
Honoraria - Bristol-Myers Squibb; Novartis; Roche Pharma AG
Consulting or Advisory Role - ARIAD; Bristol-Myers Squibb
Research Funding - Novartis
Travel, Accommodations, Expenses - Novartis; Roche Pharma AG
 
Pierre Zachee
No Relationships to Disclose
 
Masayuki Hino
No Relationships to Disclose
 
Beatriz Moiraghi
Speakers' Bureau - Bristol-Myers Squibb; Novartis
 
Carole Brennan Miller
Honoraria - Incyte
Consulting or Advisory Role - Incyte
Speakers' Bureau - Incyte
Research Funding - Incyte
 
Vittorio Rosti
No Relationships to Disclose
 
Ruben A. Mesa
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Celgene (Inst); CTI (Inst); Gilead Sciences (Inst); Incyte (Inst)
 
Mark M. Jones
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Huiling Zhen
Employment - Incyte
Stock and Other Ownership Interests - Incyte
 
Jingjin Li
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Nathalie Francillard
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Dany Habr
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jean-Jacques Kiladjian
Consulting or Advisory Role - Incyte; Novartis; Shire
Research Funding - AOP Orphan Pharmaceuticals (Inst); Novartis (Inst)